KLK3 and posterior cortical atrophy: In this study, we evaluated whether combinations of Fuc-PSA, Tie-2, and/or other selected biomarkers from an expanded list of candidates combined with current FDA approved PSA-based test modalities, specifically, prostate health index (phi) 18, could improve their diagnostic ability for the detection of AG PCa.